Inhalational Anaesthesia Drugs Market

Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient's respiratory tract, diffuse into the capillaries, and then enter the body's circulatory system and central nervous system. For inhalational anaesthesia drugs, professional equipment should be used. The patient can make the pain and consciousness disappear within a few minutes after the inhalation anesthesia, so that the operation can proceed smoothly. After stopping the medication, the patient can quickly regain self-awareness. Inhaled anesthetics are characterized by strong controllability and high safety, and they are a common method of anesthesia used in clinical practice.

Inhalational Anaesthesia Drugs Market contains market size and forecasts of Inhalational Anaesthesia Drugs in Global, including the following market information:

Global Inhalational Anaesthesia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Inhalational Anaesthesia Drugs market was valued at 1280.1 million in 2021 and is projected to reach US$ 1549.5 million by 2028, at a CAGR of 2.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Enflurane Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Inhalational Anaesthesia Drugs include AbbVie Inc., Baxter, Hikma Pharmaceuticals PLC, Halocarbon Products Corporation, Piramal Enterprises Limited and Lunan Pharmaceutical Group Co. Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Inhalational Anaesthesia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inhalational Anaesthesia Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Inhalational Anaesthesia Drugs Market Segment Percentages, by Type, 2021 (%)

Enflurane

Isoflurane

Halothane

Sevoflurane

Atropine

Global Inhalational Anaesthesia Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Inhalational Anaesthesia Drugs Market Segment Percentages, by Application, 2021 (%)

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Global Inhalational Anaesthesia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Inhalational Anaesthesia Drugs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Inhalational Anaesthesia Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Inhalational Anaesthesia Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AbbVie Inc.

Baxter

Hikma Pharmaceuticals PLC

Halocarbon Products Corporation

Piramal Enterprises Limited

Lunan Pharmaceutical Group Co. Ltd.